On 4 Oct 2026, LONGSYS (09976.HK) said its IPO stabilisation period ended on 3 Oct; the over-allotment option lapsed, so no more H shares will be issued.
On 2 Oct 2026, PATEO (02889.HK) completed the acquisition of a ~70% stake; the target was valued at RMB2.7bn with consideration capped at RMB1.4bn.
On 2 Oct 2026, a partial cash offer for TONTINE WINES (00389.HK) by Wang He lapsed after only 812,945 shares (0.27%) were accepted.
On 2 Oct 2026, YUZHOU GROUP (01628.HK) completed the disposal of its Central Centre offices; the buyer will lease the property back, terms not yet agreed.
On 2 Oct 2026, TIAN CHANG GP (02182.HK) said its unit signed a term loan facility for up to RMB280m with Bank of China Huizhou to build a magnesium alloy plant.
On 2 Oct 2026, WK GROUP (02535.HK) and WellLuck said the mandatory cash offer lapsed as conditions were unmet, with only 30,000 shares (0.0015%) accepted.
On 2 October 2026, XPeng Inc. (09868.HK) announced that it delivered 41,256 new vehicles in September 2026, up 5% month-on-month, and 118,390 new vehicles in the third quarter, up 15% quarter-on-quarter.
On 2 October 2026, GoFintech Quantum Innovation Limited (00290.HK) announced that its Fortune Asset Management Open-ended Fund Company and its two publicly offered sub-funds (the Fortune Asset Technology Select Equity Fund and the Fortune Asset Fixed Income Fund) were approved by the Securities and Futures Commission of Hong Kong on 30 September 2026.
On 2 October 2026, AInnovation Technology Group Co., Ltd. (02121.HK) announced that, under the share repurchase mandate, the Company repurchased an aggregate of 1,484,300 shares on the open market in September 2026 for a total consideration of HKD 4,922,835.50.
On 2 October 2026, Ascletis Pharma Inc. (01672.HK) announced that key preclinical data for ASC36_35FDC were presented at the 62nd Annual Meeting of the European Association for the Study of Diabete.
On 2 October 2026, EPS Health Tech Group Limited (03860.HK) announced that it expects to record an increase in loss after tax of approximately HKD 8 million to approximately HKD 12 million for the six months ended 30 September 2026 as compared with the corresponding period in 2025, mainly due to lower revenue from the IRO and CRO services business and lower gross profit of the healthcare products and pharmaceutical business.
On 2 October 2026, QYUNS-B (02509.HK) said the China Phase III data of Oturkibart in prurigo nodularis were presented at EADV 2026 and met the primary endpoint.
On 1 October 2026, SEACON (02409.HK) agreed to dispose of ship-owning units for US$133,611,758, with 30% paid in cash and 70% in buyer shares.
On 2 October 2026, SAMSONITE (01910.HK) completed the acquisition of BÉIS, LLC after all conditions were satisfied, making BÉIS an 85%-owned subsidiary.
On 1 October 2026, VALA (02051.HK) said its third model vala kcar began delivery in late September, with 420 automobiles delivered in the third quarter.
On 1 October 2026, YANCOAL AUS (03668.HK) completed the purchase of Kestrel Coal Group for USD 1.85 billion cash, gaining an 80% stake in the Kestrel mine.
